Total Funding
69
88
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3495
LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.
- Michael Kowarik: CSO & Co-Founder
- Paul Wolfrom: Co-Founder & CFO
About the Company
LimmaTech Biologics is a clinical-stage biotech company that develops vaccines to prevent life-threatening diseases. The company uses proprietary self-adjuvanting and multi-antigen vaccine platforms to address microbial infections that are becoming resistant to treatments. Its research and development efforts aim to create vaccines tailored to
specific pathogens. LimmaTech Biologics works on expanding its pipeline to provide solutions for infectious diseases with limited treatment options.
